Antispasmodic drugs relax the smooth muscles of the urinary bladder. By exerting a direct spasmolytic action on the bladder's smooth muscle, antispasmodic drugs have been reported to increase bladder capacity and effectively decrease or eliminate urge incontinence. The adverse-effect profile of antispasmodic drugs is similar to that of anticholinergic agents. These drugs may impair the patient's ability to perform activities requiring mental alertness and physical coordination. Drinking alcohol and using sedatives in combination with these antispasmodic drugs is contraindicated.
MARKET DYNAMICS
Factors driving the growth of the antispasmodics drugs market are the growing prevalence of irritable bowel syndrome, coupled with high patient awareness level and improvement in treatment. However, the product recalls is expected to hamper the growth of the market. Moreover, adoption of sedentary life style and rising investments by major market players in antispasmodics drugs is anticipated to boost the market growth.
MARKET SCOPE
The "Antispasmodics Drugs Market Analysis to 2028" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of antispasmodics drugs market with detailed market segmentation by drugs, indication, route of administration, end-users and distribution channel. The antispasmodics drugs market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in antispasmodics drugs market and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The antispasmodics drugs market is segmented on the basis of drugs, indication, route of administration, end-user and distribution channel. Based on drugs, the market is segmented as Loperamide hydrochloride, Dicyclomine hydrochloride, and others. On the basis of indication, the market is categorized as irritable bowel syndrome , stomach cramps, and others. On the basis of route of administration, the market is categorized as oral, sublingual, injectable, and others. On the basis of end-user, the market is categorized as hospitals, homecare, speciality centres, and others. Based on distribution channel, the market is segmented as hospital pharmacy, online pharmacy, and retail pharmacy.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the antispasmodics drugs market based on various segments. It also provides market size and forecast estimates from year 2020 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The antispasmodics drugs market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting antispasmodics drugs market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the antispasmodics drugs market in these regions.
MARKET PLAYERS
The report covers key developments in the antispasmodics drugs market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from antispasmodics drugs market are anticipated to have lucrative growth opportunities in the future with the rising demand for antispasmodics drugs in the global market. Below mentioned is the list of few companies engaged in the antispasmodics drugs market.
The report also includes the profiles of key players in antispasmodics drugs market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
- Allergan
- Hikma Pharmaceuticals
- Lannett
- Mylan N.V.
- Nexus Pharmaceuticals
- Akorn Incorporated
- Aurobindo Pharma
- Daiichi Sankyo, Inc
- Fresenius Kabi Ag
- Shanghai Fosun Pharmaceutical (Group) Co., Ltd
- SunGen Pharma LLC
- Others
The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.